Literature DB >> 18376121

Ryanodine receptor-mediated Ca2+ events in atrial myocytes of patients with atrial fibrillation.

Xin Liang1, Hong Xie, Pei-Hong Zhu, Jun Hu, Qiang Zhao, Chun-Sheng Wang, Cheng Yang.   

Abstract

BACKGROUND: Many alterations in sarcoplasmic reticulum Ca(2+) handling proteins in atrial myocytes have been associated with atrial fibrillation (AF) in clinical patients, whereas the functional consequences of these alterations mostly remain unclear. METHODS AND
RESULTS: To know whether or not ryanodine receptor (RyR)-mediated intracellular Ca(2+) events in AF atrial myocytes are affected by protein alterations, we investigated spontaneous Ca(2+) sparks and Ca(2+) waves in intact and permeabilized atrial myocytes of AF patients (n(patients) = 21) and normal sinus rhythm (NSR) patients (n(patients) = 22) by laser scanning confocal microscopy. It was found that the frequency, amplitude and rise time of Ca(2+) sparks were comparable between AF and NSR groups, while full width and full duration at half maximum intensity significantly increased in the AF group. Along with these changes, the frequency of small and global Ca(2+) waves increased in AF atrial myocytes.
CONCLUSIONS: Our results clearly indicated that the spatiotemporal properties but not the frequency of Ca(2+) sparks were affected in AF atrial myocytes. In addition, the frequency of Ca(2+) waves increased. This profile of the alterations in RyR-mediated Ca(2+) events in AF atrial myocytes was different from previous studies. The underlying mechanisms, as well as possible reasons for this discrepancy, were discussed. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18376121     DOI: 10.1159/000119697

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  12 in total

Review 1.  Ion Channels in the Heart.

Authors:  Daniel C Bartos; Eleonora Grandi; Crystal M Ripplinger
Journal:  Compr Physiol       Date:  2015-07-01       Impact factor: 9.090

Review 2.  Altered Excitation-Contraction Coupling in Human Chronic Atrial Fibrillation.

Authors:  Eleonora Grandi; Antony J Workman; Sandeep V Pandit
Journal:  J Atr Fibrillation       Date:  2012-04-14

Review 3.  Recent advances in the molecular pathophysiology of atrial fibrillation.

Authors:  Reza Wakili; Niels Voigt; Stefan Kääb; Dobromir Dobrev; Stanley Nattel
Journal:  J Clin Invest       Date:  2011-08-01       Impact factor: 14.808

4.  Role of abnormal sarcoplasmic reticulum function in atrial fibrillation.

Authors: 
Journal:  Therapy       Date:  2010-03-01

Review 5.  The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications.

Authors:  Dobromir Dobrev; Niels Voigt; Xander H T Wehrens
Journal:  Cardiovasc Res       Date:  2010-10-12       Impact factor: 10.787

Review 6.  Cardiac adrenergic control and atrial fibrillation.

Authors:  Antony J Workman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-04       Impact factor: 3.000

Review 7.  Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.

Authors:  Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-26       Impact factor: 3.000

Review 8.  Murine Electrophysiological Models of Cardiac Arrhythmogenesis.

Authors:  Christopher L-H Huang
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

9.  Abnormal Ca(2+) homeostasis, atrial arrhythmogenesis, and sinus node dysfunction in murine hearts modeling RyR2 modification.

Authors:  Yanmin Zhang; Gareth D K Matthews; Ming Lei; Christopher L-H Huang
Journal:  Front Physiol       Date:  2013-06-25       Impact factor: 4.566

10.  Cardiomyocyte Ca2+ handling and structure is regulated by degree and duration of mechanical load variation.

Authors:  Michael Ibrahim; Punam Kukadia; Urszula Siedlecka; James E Cartledge; Manoraj Navaratnarajah; Sergiy Tokar; Carin Van Doorn; Victor T Tsang; Julia Gorelik; Magdi H Yacoub; Cesare M Terracciano
Journal:  J Cell Mol Med       Date:  2012-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.